VerdeMed
Company Profile
Geographical Market
About
Verdemed is a Canadian pharmaceutical cannabis company whose goal is to improve the health of patients in Latin America. Based in Toronto, Canada, Verdemed’s multi-level and multi-market approach aims to bridge the gap between the European and North American cannabis pharmaceutical landscape and Latin American unmet clinical needs. Verdemed’s mission is to offer the best of approved existing and prospective cannabinoid products to all Latin Americans, in all countries and in all jurisdictions legally authorized to sell medical cannabis. The company’s focus is on product formulations of cannabinoid pharmaceuticals currently available in Canada, Europe, and the USA. Verdemed aims to meet Latin America’s medical needs with similar products and medical cannabis treatments approved by Health Canada, EMA (European Medicines Agency), and the USA FDA (Food and Drug Administration).
